A patient-centered medical home (PCMH) demonstration project did little to reduce costs and utilization or improve the quality of care, researchers found.
A patient-centered medical home (PCMH) demonstration project did little to reduce costs and utilization or improve the quality of care, researchers found.
The 3-year study of 32 small- and medium-sized primary care practices -- believed to be the first multi-payer pilot in the nation to report results over 3 years -- found that the use of a PCMH model didn't reduce hospitalizations, emergency department use, ambulatory services, or costs, according to a report in the Journal of the American Medical Association.
Furthermore, the practices showed improvement in only one of 11 quality measures -- nephropathy screening in diabetes patients -- relative to 29 comparison sites, according to Mark Friedberg, MD, of the RAND Corporation in Boston, and colleagues.
Read the full story here: http://bit.ly/Nx1DTF
Source: Med Page Today
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More